The Efficacy and Safety of Seladelpar for Primary Biliary Cholangitis: A Systematic Review and Meta‐Analysis

ABSTRACT Background and Objective Seladelpar is an oral, once‐daily medication that improves cholestasis through its selective peroxisome proliferator‐activated receptor (PPAR‐δ) agonism. It shows promising efficacy in treating primary biliary cholangitis (PBC) patients. Methods A systematic review...

詳細記述

書誌詳細

主要な著者:	Mohamed Abuelazm, Saqr Alsakarneh, Mohammad Tanashat, AlMothana Manasrah, Ahmed A. Ibrahim, Sandesh Parajuli, Hatem Eltaly, Ahmed Mazen Amin
フォーマット:	Artigo
言語:	Inglês
出版事項:	Wiley 2025-09-01
シリーズ:	JGH Open
主題:	biliary drug gallbladder hepatology liver seladelpar
オンライン･アクセス:	https://doi.org/10.1002/jgh3.70265
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!